Intelligence Β· Clinical Pipeline

AbbVie Pipeline

All ClinicalTrials.gov programs at AbbVie β€” phase, modality, and trial IDs.

Programs
5

Quick answer

AbbVie has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. ABBV-154

    AbbVie

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial
  2. ABBV-552

    AbbVie

    Alzheimer's Disease (AD)

    phase 2 small molecule completed

    1 trial
  3. Elsubrutinib

    AbbVie

    Systemic Lupus Erythematosus (SLE)

    phase 2 small molecule completed

    1 trial
  4. Upadacitinib

    AbbVie

    Hidradenitis Suppurativa (HS)

    phase 2 small molecule completed

    1 trial
  5. Upadacitinib

    AbbVie

    Non-Segmental Vitiligo

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does AbbVie have?

5 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs